Live Breaking News & Updates on Green Room Communications

Stay updated with breaking news from Green room communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023 - EyePoint Pharmaceuticals (NASDAQ:EYPT)

WATERTOWN, Mass., Oct. 31, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a company committed to developing and commercializing therapeutics to improve the lives of patients with retinal ....

United States , University Of Massachusetts Medical School , Jays Duker , Christina Tartaglia , Amy Phillips , Davidr Lally , Davids Boyer , Keck School Of Medicine , Eyepoint Pharmaceuticals Inc , Green Room Communications , Equinox Sciences , Vitreous Associates Medical Group , Retinal Surgeon At Baystate Medical Center , Eyepoint Pharmaceuticals , Point Pharmaceuticals , Chief Executive Officer , Senior Partner , Retina Vitreous Associates Medical Group , Adjunct Clinical Professor , Southern California , Keck School , Retinal Surgeon , Baystate Medical Center , Assistant Professor , Massachusetts Medical School Baystate , Retina Research Institute ,

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023

EyePoint Pharmaceuticals to Host Virtual Key Opinion Leader (KOL) Event on November 9, 2023
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , University Of Massachusetts Medical School , Davidr Lally , Davids Boyer , Jays Duker , Christina Tartaglia , Amy Phillips , Eyepoint Pharmaceuticals Nasdaq , Keck School Of Medicine , Retinal Surgeon At Baystate Medical Center , Eyepoint Pharmaceuticals , Equinox Sciences , Vitreous Associates Medical Group , Green Room Communications , Eyepoint Pharmaceuticals Inc , Point Pharmaceuticals , Host Virtual Key Opinion Leader , Chief Executive Officer , Senior Partner , Retina Vitreous Associates Medical Group , Adjunct Clinical Professor , Southern California , Keck School , Retinal Surgeon , Baystate Medical Center , Assistant Professor ,

EyePoint Pharmaceuticals Announces Presentations at Eyecelerator 2023, American Academy of Ophthalmology Annual Meeting 2023 and Guggenheim's 5th Annual Inflammation, Neurology & Immunology Conference 2023 -October 30, 2023 at 07:01 am EDT

WATERTOWN, Mass., Oct. 30, 2023 EyePoint Pharmaceuticals, Inc. , a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with retinal. ....

United States , Christina Tartaglia , Amy Phillips , Jays Duker , American Academy Of Ophthalmology , Eyepoint Pharmaceuticals Inc , Globenewswire Inc , Panel Discussion , Green Room Communications , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Nasdaq , Point Pharmaceuticals , Chief Executive Officer , Annual Meeting , Receptor Inhibition , Tyrosine Kinase Inhibitor Vorolanib , Immunology Conference ,

Mallinckrodt Presents Latest Health Economics Data on Acthar® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023

/PRNewswire/ Mallinckrodt plc (OTCMKTS: MNKTQ), a global specialty pharmaceutical company, recently shared findings from Mallinckrodt s latest health. ....

United States , Danielj Speciale , Prnewswire Mallinckrodt , Derek Belz , Drug Administration , American College Of Chest Physicians , Symphony Health , Outcomes Research On , Mallinckrodt Pharmaceuticals , Academy Of Managed Care Pharmacy , National Institute Of Health , Green Room Communications , Data Sciences , Exchange Commission , National Institute Of Diabetes , Nephcure Kidney International , Acthar Gel , Managed Care Pharmacy , Important Safety Information , Advanced Symptomatic Sarcoidosis , Outcomes Research , Patient Characteristics , Treatment Patterns , Related Outcomes After Treatment , Comparable Standard , Large Administrative Claims ,

EyePoint Pharmaceuticals to Report Third Quarter 2023

WATERTOWN, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing. ....

United States , Christina Tartaglia , Amy Phillips , Eyepoint Pharmaceuticals Nasdaq , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Green Room Communications , Point Pharmaceuticals , Nasdaq Eypt , Eyepoint Pharmaceuticals , Eyepoint Pharma ,